Profile
Claudio Dansky Ullmann formerly worked at Takeda Pharmaceutical Co., Ltd., as Senior Medical Director from 2012 to 2015, MaxCyte, Inc., as Chief Medical Officer, Infinity Pharmaceuticals, Inc., as Senior Vice President-Clinical Development, Avenge Bio, Inc., as Chief Medical Officer, and Context Therapeutics, Inc., as Chief Medical Officer from 2024 to 2025.
Dr. Ullmann received his graduate degree from Universidad de Buenos Aires.
Former positions of Claudio Ullmann
| Companies | Position | End |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 10/05/2025 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Chief Tech/Sci/R&D Officer | - |
| MAXCYTE, INC. | Chief Tech/Sci/R&D Officer | - |
| INFINITY PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Claudio Ullmann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Universidad de Buenos Aires
Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Health Technology |
Context Therapeutics, Inc.
Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
- Stock Market
- Insiders
- Claudio Ullmann
















